IMPE Abstracts

Background: Gonadotropin-releasing hormone (GnRH) analogs are widely used in the treatment of central precocious puberty (CPP). Triptorelin is available as 1-month and 3-month prolonged release (PR) formulations, but only the former is approved for CPP in China. This phase 3 study assessed whether the effectiveness of triptorelin 3-month PR formulation in Chinese children with CPP was comparable to overseas children.Methods:</str...